Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03358342 · ClinicalTrials.gov registry record
ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 10,000
- Enrollment target
NCT03358342: Completed study, sponsored by Intermountain Health Care.
NCT03358342 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 10,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03358342 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 10,000 participants
- Enrollment target
Study Summary
The investigators plan to further develop a prototype, evidence-based, electronic clinical decision support system (CDSS) for pneumonia care (ePneumonia) with interoperability across Electronic Health Records in order to improve clinical outcomes and reduce healthcare resource utilization. The specific aims of this study are to evaluate the usability of ePneumonia adapted for Cerner and its impact on clinical, patient-centered and healthcare resource utilization outcomes in a stepped-wedge implementation study in 16 hospital emergency departments (EDs) across the Intermountain Healthcare integrated health system.
Primary Outcome
mortality within 30 days of initial ED visit
Interventions
- OTHER ePneumonia CDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2017-11-22 |
| Est. Completion | 2019-12-31 |
What the finished NCT03358342 record still lists
NCT03358342 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which ePneumonia CDS is the first listed.
NCT03358342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03358342 about?
NCT03358342 is a clinical study titled "ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia". The investigators plan to further develop a prototype, evidence-based, electronic clinical decision support system (CDSS) for pneumonia care (ePneumonia) with interoperability across Electronic Health Records in order to improve clinical outcomes and reduce healthcare resource utilization. The speci...
What is the current status of trial NCT03358342?
This trial is currently completed. The enrollment target is 10,000 participants. The study started on 2017-11-22. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03358342?
The interventions under investigation include: ePneumonia CDS (OTHER).
Who is sponsoring clinical trial NCT03358342?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI